Evaxion A (EVAX) Cash & Equivalents (2019 - 2026)

Evaxion A (EVAX) reported Cash & Equivalents of $18.4 million for Q1 2026, up 3.35% on a YoY basis from $17.8 million in Q1 2025, and down 20.63% quarter-over-quarter from $23.2 million in Q4 2025.

Evaxion A (EVAX) Cash & Equivalents (2019 - 2026) Analysis & Trends

Evaxion A has reported Cash & Equivalents for 8 years, with the latest figure at $18.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Equivalents rose 3.35% year-over-year to $18.4 million; the trailing twelve-month figure through Mar 2026 stood at $18.4 million (up 3.35% YoY), and the FY2025 full-year result was $23.2 million, up 290.36% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $18.4 million, down from $23.2 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $31.4 million in Q1 2022, with the low at $11731.0 in Q1 2024.
  • Historically, Cash & Equivalents has averaged $13.3 million across 5 years, with a median of $11.9 million in 2022.
  • Annual changes were most pronounced in 2024 — Cash & Equivalents slumped 99.89% — and 2025, when it soared 152001.27%.
  • Evaxion A's Cash & Equivalents stood at $13.2 million in 2022, then sank by 57.65% to $5.6 million in 2023, then increased by 6.61% to $6.0 million in 2024, then jumped by 290.36% to $23.2 million in 2025, then retreated by 20.63% to $18.4 million in 2026.
  • The last three Cash & Equivalents figures came in at $18.4 million (Q1 2026), $23.2 million (Q4 2025), and $10.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 32.30 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 1.91 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 286.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 18.44 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 2.77 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.49 Bn
9 Abivax 91.96 Bn 91.96 Bn - 558.94 Mn
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 2.96 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 18.44 Mn
Dec 31, 2025 23.23 Mn
Sep 30, 2025 10.57 Mn
Jun 30, 2025 14.75 Mn
Mar 31, 2025 17.84 Mn
Dec 31, 2024 5.95 Mn
Jun 30, 2024 7.99 Mn
Mar 31, 2024 11,731.00
Dec 31, 2023 5.58 Mn
Sep 30, 2023 2.61 Mn
Jun 30, 2023 7.12 Mn
Mar 31, 2023 10.24 Mn
Dec 31, 2022 13.18 Mn
Sep 30, 2022 17.85 Mn
Jun 30, 2022 25.25 Mn
Mar 31, 2022 31.41 Mn
Dec 31, 2021 32.17 Mn
Sep 30, 2021 11.94 Mn
Jun 30, 2021 18.80 Mn
Mar 31, 2021 26.96 Mn